» Articles » PMID: 27798432

HIV-Related Sexual Risk Among Transgender Men Who Are Gay, Bisexual, or Have Sex With Men

Overview
Date 2016 Nov 1
PMID 27798432
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study is among the first to examine factors associated with HIV-related sexual risk among transgender men and other transmasculine persons who are gay, bisexual, or have sex with men (T-GBMSM).

Methods: In 2009-2010, 433 transgender people in Ontario, Canada, participated in a multimode respondent-driven sampling survey, including 158 T-GBMSM. Analyses were weighted using respondent-driven sampling II methods to adjust for differential recruitment probabilities; confidence intervals (CI) were adjusted for clustering by shared recruiter. Prevalence ratios (PR) for associations with past-year high sexual risk (condomless intercourse outside a seroconcordant monogamous relationship) were estimated using average marginal predictions from logistic regression.

Results: Of T-GBMSM (mean age = 29.8; 52% living full time in felt gender; 25% Aboriginal or persons of color; 0% self-reported HIV positive), 10% had high sexual risk activity in the past year. Among the 34% with a past-year cisgender (non-transgender) male sex partner, 29% had high sexual risk. In multivariable analyses, older age, childhood sexual abuse (adjusted PR, APR = 14.03, 95% CI: 2.32 to 84.70), living full time in one's felt gender (APR = 5.20, 95% CI: 1.11 to 24.33), and being primarily or exclusively attracted to men (APR = 5.54, 95% CI: 2.27 to 13.54) were each associated with sexual risk. Of psychosocial factors examined, past-year stimulant use (APR = 4.02, 95% CI: 1.31 to 12.30) and moderate depressive symptoms (APR = 5.77, 95% CI: 1.14 to 29.25) were associated with higher sexual risk.

Conclusions: T-GBMSM seem to share some HIV acquisition risk factors with their cisgender counterparts. HIV prevention interventions targeting T-GBMSM who are predominantly attracted to men and interventions addressing sequelae of childhood sexual abuse may be warranted.

Citing Articles

Brief Report: Genital Microbiome, Inflammation, and Tenofovir Levels in Transgender Men and Cisgender Women Taking Oral PrEP.

Hastie E, Srivatsa M, Gianella S, Cottrell M, Forsyth K, Porrachia M J Acquir Immune Defic Syndr. 2025; 97(5):477-481.

PMID: 39792141 PMC: 11724185. DOI: 10.1097/QAI.0000000000003521.


Brief Report:Availability of and Interest in Gender-Affirming Care, PrEP, and HIV Prevention Services in a Global Sample of Transmasculine Persons.

Paine E, Appenroth M, Scheim A, Goldrich M, Giguere R, Sandfort T J Acquir Immune Defic Syndr. 2025; 97(5):471-476.

PMID: 39792140 PMC: 11882134. DOI: 10.1097/QAI.0000000000003512.


Long-Acting Injectable Pre-Exposure Prophylaxis Perceptions and Preferences Among Transgender and Nonbinary Young Adults in the United States.

Gordon A, Haiken S, Murchison G, Agenor M, Hughto J, Nelson K Qual Health Res. 2024; 35(1):74-87.

PMID: 39095331 PMC: 11869390. DOI: 10.1177/10497323241265943.


Latent Constructs of Economic Marginality Associated with Sexual Behavior, Healthcare Access and HIV Outcomes Among Transgender and Nonbinary People in Three U.S. Cities.

Paine E, Rivera-Cash D, Lopez J, LeBlanc A, Singh A, Bockting W AIDS Behav. 2023; 28(4):1197-1209.

PMID: 37698637 PMC: 11218028. DOI: 10.1007/s10461-023-04143-8.


Heterogeneity in HIV/Sexually Transmitted Infection Prevalence and Prevention Among the Partners of Transgender and Nonbinary People.

Tordoff D, Minalga B, Perry N, Gross B, Khosropour C, Glick S Sex Transm Dis. 2023; 50(5):280-287.

PMID: 36881439 PMC: 11243647. DOI: 10.1097/OLQ.0000000000001796.